KalVista Pharmaceuticals
KALV
#6265
Rank
โ‚ฌ0.72 B
Marketcap
14,37ย โ‚ฌ
Share price
0.03%
Change (1 day)
60.33%
Change (1 year)

Revenue for KalVista Pharmaceuticals (KALV)

Revenue in 2025 (TTM): โ‚ฌ12.91 Million

According to KalVista Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ12.88 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for KalVista Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ12.91 M
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚ฌ3.1 M-70.47%
2019 โ‚ฌ10.52 M-33.25%
2018 โ‚ฌ15.76 M415.84%
2017 โ‚ฌ3.05 M1095.37%
2016 โ‚ฌ0.25 M864.22%
2015 โ‚ฌ0.02 M11.23%
2014 โ‚ฌ0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA